Cardano is trading around $0.175, following a 1.03% drop after the network outlined its two-phase Dijkstra hard fork development schedule. The new roadmap details a series of protocol enhancements set for the last quarter of 2026 and the second quarter of 2027, targeting both scalability and transaction speed improvements.
Dijkstra upgrade roadmap and technical milestones
The first phase of the Dijkstra upgrade is planned for the fourth quarter of 2026, when Cardano is expected to move to protocol version 12. This update will bring the introduction of Ouroboros Linear Leios, support Nested Transactions, and add Script Context capabilities in PlutusV4. As part of this rollout, the groundwork for Ouroboros Peras—the next consensus protocol—will also be laid.
In the second phase, which is scheduled for the second quarter of 2027, Cardano developers aim to activate Ouroboros Peras through another hard fork. This protocol is intended to enhance transaction confirmation times, potentially leading to faster settlements throughout the network.
These dates represent internal development targets rather than fixed mainnet releases. Each stage must undergo rigorous testing on the Preview and Pre-production networks before being deployed to Cardano’s main blockchain.
ETH
SOL
BSC
ROBINHOOD
USDT
AAPLMini dictionary: Ouroboros Linear Leios and Peras, specialized Cardano consensus protocols designed to improve blockchain scalability and transaction settlement speed.
Governance, market reaction, and whale activity
Execution of the Dijkstra upgrades depends heavily on Cardano’s decentralized governance system. For any protocol change to be enacted, approval is required from Delegated Representatives (DReps), stake pool operators, and Cardano’s Constitutional Committee. This process aims to ensure broad community consensus for significant network alterations.
Market analyst Sjuul from AltCryptoGems commented that ADA continues to decline as predicted. He attributed this to a breakdown in the market structure and described recent altcoin rallies as weak and largely driven by capital rotation among different cryptocurrencies, rather than sustained momentum.
ADA remains under pressure, following a bearish breakdown, with capital quickly rotating between altcoins instead of supporting a broad rally.
On-chain analytics from Santiment indicated notable selling activity among large Cardano holders. Addresses with between one million and 100 million ADA coins have offloaded approximately 200 million ADA tokens since August 11. While some smaller whale cohorts have absorbed part of this selling, the trend suggests a distribution phase among larger investors.
Futures and technical indicators
Derivatives data underscores a cautious outlook. Figures from CoinGlass show the long-to-short ratio at 0.92 on Monday, below the neutral threshold of 1.0. Funding rates turned negative, meaning short positions are currently compensating longs, which generally signals a bearish sentiment.
Spot ADA trading volumes surged nearly 90% to $388.36 million, while derivatives volume spiked 151% to $15.56 million. Despite this, open interest in ADA futures declined 1.76% to $451.31 million, indicating that some traders have unwound or closed their leveraged positions.
| Metric | Current Value | Change |
|---|---|---|
| Spot trading volume | $388.36 million | +89.88% |
| Derivatives volume | $15.56 million | +151.19% |
| Open interest | $451.31 million | -1.76% |
Technically, ADA’s Relative Strength Index is near 34, placing the coin in oversold territory. Immediate resistance stands at the 50-day EMA at $0.179, while the 100-day EMA sits at $0.194. The MACD is also displaying negative momentum, and ADA currently trades below a tight batch of Exponential Moving Averages on the daily chart. A close under $0.173 could open the way for a drop toward support near $0.150.
The Chaikin Money Flow indicator reached 0.19, suggesting there is some positive capital inflow despite the recent price decline.
Cardano’s Dijkstra development timeline signals major upgrades ahead, but persistent selling from large investors and weak technical readings continue to weigh on ADA’s near-term outlook.
